Press releases September 8, 2021

Eirion Therapeutics Announces Strategic Agreement

As part of the agreement, HTL will build, validate and operate a botulinum manufacturing facility in the US. In the future, HTL Biotechnology expects to apply to the CDC to have the facility certified to manufacture botulinum and later apply to the FDA to have it certified as a GMP plant.

Read more below.

To see our most recent news,
follow us on LinkedIn

Go to our LinkedIn page

Read more
news from us

Articles April 13, 2026
EcoVadis Platinum Level Achieved in 2026

We have renewed our EcoVadis assessment and achieved the Platinum level!
Articles March 19, 2026
HTL Biotechnology at PCHi 2026 in Hangzhou

HTL Biotechnology recently took part in PCHi (Personal Care and Homecare Ingredients), one of the leading events for the personal care industry, held in Hangzhou, China.
Articles February 16, 2026
Lunar New Year 2026: Entering the Year of the Fire Horse

From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.